All-purpose HSCs

While most eyes are on hematopoietic stem cells for their ability to treat blood cancers, a UCSD group has built a body of work showing the immune cell precursors can treat diseases with no relation to the immune system, and has spun out GenStem Therapeutics Inc. to develop the technology.

The company was formed last year based on work from the lab of Stephanie Cherqui, an associate professor in the Department of Pediatrics at the University of California San Diego. Its funding is undisclosed...